APA

Lodise T. P., Drusano G. L., Lazariu V., El-Fawal N., Evans A., Graffunder E., Stellrecht K., Mendes R. E., Jones R. N., Cosler L. & McNutt L. A. (20150410). Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin. : The Journal of antimicrobial chemotherapy.

Chicago

Lodise T P, Drusano G L, Lazariu V, El-Fawal N, Evans A, Graffunder E, Stellrecht K, Mendes R E, Jones R N, Cosler L and McNutt L A. 20150410. Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin. : The Journal of antimicrobial chemotherapy.

Harvard

Lodise T. P., Drusano G. L., Lazariu V., El-Fawal N., Evans A., Graffunder E., Stellrecht K., Mendes R. E., Jones R. N., Cosler L. and McNutt L. A. (20150410). Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin. : The Journal of antimicrobial chemotherapy.

MLA

Lodise T P, Drusano G L, Lazariu V, El-Fawal N, Evans A, Graffunder E, Stellrecht K, Mendes R E, Jones R N, Cosler L and McNutt L A. Quantifying the matrix of relationships between reduced vancomycin susceptibility phenotypes and outcomes among patients with MRSA bloodstream infections treated with vancomycin. : The Journal of antimicrobial chemotherapy. 20150410.